NCT02389816 A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT02385786 Mindfulness-Based Cognitive Therapy Effect on Depression and C-Reactive Protein Levels After 8 Weeks of Treatment Status COMPLETED Phase NA
NCT02383693 Maintenance rTMS for Treatment-resistant Depression (TRD): a One-year Double Blind Controlled Study Status UNKNOWN Phase PHASE2/PHASE3
NCT02378714 Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers Status COMPLETED Phase PHASE4
NCT02376257 Improving Therapeutic Learning in Depression: Proof of Concept Status COMPLETED Phase PHASE2
NCT02375308 Efficacy of Cognitive Behavioral to Hypnotherapeutic Treatment of Depression Status COMPLETED Phase NA
NCT02372799 Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22) Status COMPLETED Phase PHASE3
NCT02371980 Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE4
NCT02369393 Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical Activity Status COMPLETED Phase NA
NCT02366364 Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02362529 Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder Status COMPLETED Phase EARLY_PHASE1
NCT02361684 e-Compared-S: Comparative Effectiveness Research on Internet-based Depression Treatment - Spanish Trial Status COMPLETED Phase NA
NCT02356107 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females Status COMPLETED Phase PHASE4
NCT02339285 Transcranial Alternating Current Stimulation for Major Depressive Disorder Status COMPLETED Phase NA
NCT02334228 Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness Status COMPLETED Phase NA
NCT02332954 Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine Status COMPLETED Phase PHASE4